(Q44687792)

5 December 2017

title

Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach (English)

1 reference

5 December 2017

1

1 reference

5 December 2017

8

1 reference

5 December 2017

2

Alfredo Cesario

1 reference

5 December 2017

3

Stefano Margaritora

1 reference

5 December 2017

4

Venanzio Porziella

1 reference

5 December 2017

7

Lucio Trodella

1 reference

5 December 2017

5

Giuseppe Macis

1 reference

5 December 2017

9

Pierluigi Granone

1 reference

5 December 2017

6

Rolando M D'Angelillo

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

The Annals of Thoracic Surgery

5 December 2017

published in

1 reference

5 December 2017

volume

76

1 reference

5 December 2017

issue

6

1 reference

5 December 2017

page(s)

1802-8; discussion 1808-9

1 reference

5 December 2017

cites work

Cancer statistics, 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Revisions in the International System for Staging Lung Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

The role of surgery in N2 lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Randomised multicentre trials of CHART vs conventional radiotherapy in head and neck and non-small-cell lung cancer: an interim report. CHART Steering Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Preoperative chemotherapy (cisplatin and fluorouracil) and radiation therapy in stage III non-small-cell lung cancer: a phase II study of the Lung Cancer Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Preoperative chemotherapy and irradiation for stage III non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

The effects of preoperative chemotherapy on the resectability of non-small cell lung carcinoma with mediastinal lymph node metastases (N2 M0).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Simultaneous cisplatin fluorouracil infusion and radiation followed by surgical resection in regionally localized stage III, non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

A phase II study of 72-hour continuous infusion consisting of cisplatin and 5-fluorouracil for treatment of non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Phase II Trial of High-Dose 24-Hour Continuous Intravenous 5-Fluorouracil for Advanced Non-Small Cell Lung Cancer: A Cancer and Leukemia Group B Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Endpoints for multimodal clinical trials in stage III non-small cell lung cancer (NSCLC): a consensus report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Nonparametric Estimation from Incomplete Observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Clinical practice guidelines for the treatment of unresectable non-small-cell lung cancer. Adopted on May 16, 1997 by the American Society of Clinical Oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Neoadjuvant therapy: a novel and effective treatment for stage IIIb non-small cell lung cancer. Southwest Oncology Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Induction chemoradiotherapy for advanced stage III non-small cell lung cancer: long-term follow-up in 42 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Induction chemotherapy for T4 centrally located non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Preoperative chemoradiotherapy and surgery for selected non-small cell lung cancer IIIB subgroups: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Surgery as part of combined modality treatment in stage IIIB non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Benefit of surgery after chemoradiotherapy in stage IIIB (T4 and/or N3) non-small cell lung cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2803%2901063-4

10.1016/S0003-4975(03)01063-4

7 January 2021

Identifiers

DOI

1 reference

5 December 2017

1 reference